The Glasgow Benefit Inventory—Assessment of Patients Who Underwent Laser-Assisted Dacryocystorhinostomy (LDCR)

<b>Background/Objectives:</b> Disruptions in lacrimal function can lead to various conditions, including chronic nasolacrimal duct obstruction and dacryocystitis, which may cause symptoms like excessive tearing, pain, and recurrent infections. In cases where pharmacological treatments are insufficient, surgical intervention becomes essential, which is widely used to restore effective tear drainage. <b>Methods:</b> This study evaluated postoperative outcomes of laser-assisted dacryocystorhinostomy (LDCR) in 48 patients, totaling 56 treated eyes, over a follow-up period of 6 months to 3.5 years. During the follow-up examination, patients completed the Glasgow Benefit Inventory questionnaire. <b>Results:</b> The outcomes demonstrated significant improvements, particularly in the GBI total score (+35.07) and general subscale (+44.36), with minimal effects on social support and physical health subscales. <b>Conclusions:</b> LDCR proves to be an effective, minimally invasive alternative to traditional dacryocystorhinostomy, offering significant patient satisfaction, faster recovery, and reduced complications in treating nasolacrimal duct obstruction.